Dkk-1 secreted by mesenchymal stem cells inhibits growth of breast cancer cells via depression of Wnt signalling

Cancer Letters

Volumn 269, Issue 1, 2008, Pages 67-77

  Qiao, Ling ^a   Xu, Zhi li ^a   Zhao, Tie jun ^a   Ye, Li hong ^a   Zhang, Xiao dong ^a  

^a NANKAI UNIVERSITY   (China)

Author keywords

Breast cancer; Dickkopf 1 (Dkk 1); Mesenchymal stem cell; Wnt signalling pathway

Indexed keywords

BETA CATENIN; DICKKOPF 1 PROTEIN; MESSENGER RNA; PROTEIN; SMALL INTERFERING RNA; WNT PROTEIN;

ANIMAL CELL; ARTICLE; BREAST CANCER; CANCER INHIBITION; CELL STRAIN MCF 7; CONTROLLED STUDY; HUMAN; HUMAN CELL; MESENCHYMAL STEM CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; PROTEIN TARGETING;

ANIMALS; BETA CATENIN; BREAST NEOPLASMS; CELL PROLIFERATION; CELLS, CULTURED; CULTURE MEDIA, CONDITIONED; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MESENCHYMAL STEM CELLS; MICE; MICE, SCID; SIGNAL TRANSDUCTION; WNT PROTEINS;

EID: 49349100584     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2008.04.032     Document Type: Article

References (40)

1. Tutter A.V., Baltus G.A., and Kadam S. Embryonic stem cells: a great hope for a new era of medicine. Curr. Opin. Drug Discov. Devel. 9 (2006) 169-175
2. Renga M., Pedrazzoli P., and Siena S. Present results and perspectives of allogeneic non-myeloablative hematopoietic stem cell transplantation for treatment of human solid tumours. Ann. Oncol. 14 (2003) 1177-1184
3. Kim S.K., Cargioli T.G., and Machluf M. PEX-producing human neural stem cells inhibit tumour growth in a mouse glioma model. Clin. Cancer Res. 11 (2005) 5965-5970
4. Yuan X., Hu J., and Belladonna M.L. Interleukin-23-expressing bone marrow-derived neural stem-like cells exhibit antitumour activity against intracranial glioma. Cancer Res. 66 (2006) 2630-2638
5. Wulf G.G., Chapuy B., and Trumper L. Mesenchymal stem cells from bone marrow. Phenotype, aspects of biology, and clinical perspectives. Med. Klin. (Munich) 101 (2006) 408-413
6. Nakamizo A., Marini F., and Amano T. Human bone marrow-derived mesenchymal stem cells in the treatment of gliomas. Cancer Res. 65 (2005) 3307-3318
7. Khakoo A.Y., Pati S., and Anderson S.A. Human mesenchymal stem cells exert potent antitumourigenic effects in a model of Kaposi's sarcoma. J. Exp. Med. 203 (2006) 1235-1247
8. Lu Y.R., Yuan Y., Wang X.J., Wei L.L., Chen Y.N., Cong C., Li S.F., Long D., Tan W.D., Mao Y.Q., Zhang J., Li Y.P., and Cheng J.Q. The growth inhibitory effect of mesenchymal stem cells on tumor cells in vitro and in vivo. Cancer Biol Ther. 7 (2008) 245-253
9. Lindvall C., Evans N.C., and Zylstra C.R. The WNT signaling receptor, LRP5, is required for mammary ductal stem cell activity and WNT1-induced tumourigenesis. J. Biol. Chem. 281 (2006) 35081-35087
10. Reya T., and Clevers H. Wnt signalling in stem cells and cancer. Nature 434 (2005) 843-850
11. Neth P., Ciccarella M., and Egea V. Wnt signaling regulates the invasion capacity of human mesenchymal stem cells. Stem Cells 24 (2006) 1892-1903
12. Androutsellis-Theotokis A., Leker R.R., and Soldner F. Notch signalling regulates stem cell numbers in vitro and in vivo. Nature 442 (2006) 823-826
13. Gaspar C., and Fodde R. APC dosage effects in tumourigenesis and stem cell differentiation. Int. J. Dev. Biol. 48 (2004) 377-386
14. Chen G., Shukeir N., and Potti A. Up-regulation of Wnt-1 and beta-catenin production in patients with advanced metastatic prostate carcinoma: potential pathogenetic and prognostic implications. Cancer 101 (2004) 1345-1356
15. Moon R.T., Kohn A.D., and De-Ferrari G.V. WNT and beta-catenin signalling: diseases and therapies. Nat. Rev. Genet. 5 (2004) 691-701
16. Yang F., Zeng Q., Yu G., Li S., and Wang C.Y. Wnt/beta-catenin signaling inhibits death receptor-mediated apoptosis and promotes invasive growth of HNSCC. Cell. Signal. 18 (2006) 679-687
17. Baek S.H., Kioussi C., and Briata P. Regulated subset of G1 growth-control genes in response to derepression by the Wnt pathway. Proc. Natl. Acad. Sci. USA 100 (2003) 3245-3250
18. Muncan V., Sansom O.J., and Tertoolen L. Rapid loss of intestinal crypts upon conditional deletion of the Wnt/Tcf-4 target gene c-Myc. Mol. Cell. Biol. 10 (2006) 1128
19. Byun T., Karimi M., and Marsh J.L. Expression of secreted Wnt antagonists in gastrointestinal tissues: potential role in stem cell homeostasis. J. Clin. Pathol. 58 (2005) 515-519
20. Mao B., Wu W., and Li Y. LDL-receptor-related protein 6 is a receptor for Dickkopf proteins. Nature 411 (2001) 321-325
21. Brott B.K., and Sokol S.Y. Regulation of Wnt/LRP signaling by distinct domains of Dickkopf proteins. Mol. Cell. Biol. 22 (2002) 6100-6110
22. Qiao L., Xu Z., Zhao T., Zhao Z., Shi M., Zhao R.C., Ye L., and Zhang X. Depression of tumorigenesis mediated by human mesenchymal stem cells in a model of hepatoma cells. Cell Res. 18 (2008) 500-507
23. Zhao Z., Liao L., and Cao Y. Establishment and properties of fetal dermis-derived mesenchymal stem cell lines: plasticity in vitro and hematopoietic protection in vivo. Bone Marrow Transplant. 36 (2005) 355-365
24. Wang F.Z., Sha L., Zhang W.Y., Wu L.Y., Qiao L., Li N., Zhang X., and Ye L. Involvement of hepatitis B X-interacting protein (HBXIP) in proliferation regulation of cells. Acta Pharmacol. Sin. 28 (2007) 431-438
25. Prockop D.J., Gregory C.A., and Spees J.L. One strategy for cell and gene therapy: harnessing the power of adult stem cells to repair tissues. Proc. Natl. Acad. Sci. USA 100 (2003) 11917-11923
26. Workman P., Twentyman P., Balkwill F., Balmain A., Chaplin D., Double J., Embleton J., Newell D., Raymond R., Stables J., Stephens T., and Wallace J. United Kingdom co-ordinating committee on cancer research (UKCCCR) guidelines for the welfare of animals in experimental neoplasia (second edition). Br. J. Cancer 77 (1998) 1-10
27. Chua C.W., Lee D.T., and Ling M.T. FTY720, a fungus metabolite, inhibits in vivo growth of androgen-independent prostate cancer. Int. J. Cancer 117 (2005) 1039-1048
28. Kaiser M.J., Tiegs G., and Neuhuber W.L. Close apposition of dynorphin-positive nerve fibres to lymphocytes in the liver suggests opioidergic neuroimmunomodulation. Histochem. Cell Biol. 120 (2003) 213-221
29. Yamaguchi Y., Itami S., and Watabe H. Mesenchymal-epithelial interactions in the skin: increased expression of dickkopf1 by palmoplantar fibroblasts inhibits melanocyte growth and differentiation. J. Cell Biol. 165 (2004) 275-285
30. Hall C.L., Bafico A., and Dai J. Prostate cancer cells promote osteoblastic bone metastases through Wnts. Cancer Res. 65 (2005) 7554-7560
31. Gonzalez-Sancho J.M., Aguilera O., and Garcia J.M. The Wnt antagonist DICKKOPF-1 gene is a downstream target of beta-catenin/TCF and is downregulated in human colon cancer. Oncogene 24 (2005) 1098-1103
32. Aguilera O., Fraga M.F., Ballestar E., Paz M.F., Herranz M., Espada J., Garcia J.M., Munoz A., Esteller M., and Gonzalez-Sancho J.M. Epigenetic inactivation of the Wnt antagonist DICKKOPF-1 (DKK-1) gene in human colorectal cancer. Oncogene 25 (2006) 4116-4121
33. Etheridgea S.L., Spencer G.J., Heath D.J., and Genever P.G. Expression profiling and functional analysis of Wnt signaling mechanisms in mesenchymal stem cells. Stem Cells 22 (2004) 849-860
34. Khor T.O., Gul Y.A., and Ithnin H. A comparative study of the expression of Wnt-1, WISP-1, survivin and cyclin-D1 in colorectal carcinoma. Int. J. Colorectal Dis. 21 (2006) 291-300
35. Mikheev A.M., Mikheeva S.A., and Liu B. A functional genomics approach for the identification of putative tumour suppressor genes: Dickkopf-1 as suppressor of HeLa cell transformation. Carcinogenesis 25 (2004) 47-59
36. Shou J., Ali-Osman F., and Multani A.S. Human Dkk-1, a gene encoding a Wnt antagonist, responds to DNA damage and its overexpression sensitizes brain tumour cells to apoptosis following alkylation damage of DNA. Oncogene 21 (2002) 878-889
37. Studeny M., Marini F.C., and Dembinski J.L. Mesenchymal stem cells: potential precursors for tumour stroma and targeted-delivery vehicles for anticancer agents. J. Natl. Cancer Inst. 96 (2004) 593-1603
38. Gregory C.A., Singh H., and Perry A.S. The Wnt signaling inhibitor Dickkopf-1 is required for reentry into the cell cycle of human adult stem cells from bone marrow. J. Biol. Chem. 278 (2003) 28067-28078
39. Kuphal S., Lodermeyer S., Bataille F., Schuierer M., Hoang B.H., and Bosserhoff A.K. Expression of Dickkopf genes is strongly reduced in malignant melanoma. Oncogene 25 (2006) 5027-5036
40. Qiao L., Zhao T., Wang F., Shan C., Ye L., and Zhang X. NF-κB downregulation may be involved the depression of proliferation of tumor cells mediated by human mesenchymal stem cells. Acta Pharmacol. Sin. 29 (2008) 333-340